Oncotarget (IMAGE)
Caption
Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability
Credit
2023 Xavier et al.
Usage Restrictions
Original Content
License
Original content